A Study to Evaluate the Safety and Immunogenicity of Different Doses of ExPEC4V (JNJ-63871860) in Healthy Japanese Adult Participants
Clinical trial NCT02748967 · COMPLETED
Trial details
- NCT number
- NCT02748967
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2016-08-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.